Skip to main content
SpringerLink
Log in

Tumoren der Leber

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 3914 Accesses

Zusammenfassung

Das Kapitel beschreibt neben der Pathologie primärer benigner und maligner Lebertumoren auch deren Ätiologie, Pathophysiologie, Therapie und Prognose. Der derzeitige Stand der molekularpathologischen Alterationen wird dargestellt, auch unter Berücksichtigung ihrer diagnostischen Wertigkeit. Die unterschiedlichen Entitäten werden unter dem Aspekt wichtiger, differentialdiagnostischer Parameter beschrieben. Die neue, aktuelle Subdifferenzierung der Leberzelladenome wird hinsichtlich ihrer klinischen Wertigkeit abgehandelt – immer vor dem Hintergrund der klinischen Bedeutung der Pathologie. Zahlreiche Abbildungen illustrieren die histopathologischen und auch makroskopischen Veränderungen. Die Tabellen fassen die Differentialdiagnosen prägnant zusammen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 309.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 399.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Akifuji Y, Honjo I, Katayama S, Ishitobi S, Ueki J, Kishi K, Kato K, Nakamoto S (1992) Malignant fibrous histiocytoma of the liver: a case report and review of the literature. Intern Med 31:284–288

    Article  CAS  PubMed  Google Scholar 

  2. Al-Mukhaizeem KA, Rosenberg A, Sherker AH (2004) Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 75:225–230

    Article  PubMed  Google Scholar 

  3. Alrenga DP (1975) Primary fibrosarcoma of the liver. Case report and review of the literature. Cancer 36:446–449

    Article  CAS  PubMed  Google Scholar 

  4. Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O’Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK (2013) Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res 6:3–9

    PubMed  PubMed Central  Google Scholar 

  5. Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26:217–233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978

    Article  PubMed  Google Scholar 

  7. Bellamy CO, Maxwell RS, Prost S, Azodo IA, Powell JJ, Manning JR (2013) The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. Histopathology 62:431–445

    Article  PubMed  Google Scholar 

  8. Bosetti C, La Vecchia C, Lipworth L, McLaughlin JK (2003) Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature. Eur J Cancer Prev 12:427–430

    Article  CAS  PubMed  Google Scholar 

  9. WHO classification of tumours Editorial Board (Hrsg) (2019) Digestive system tumours. Fifth edition. Volume 1. International Agency for Research on Cancer, Lyon

    Google Scholar 

  10. Budd GT (2002) Management of angiosarcoma. Curr Oncol Rep 4:515–519

    Article  PubMed  Google Scholar 

  11. Darbari A, Sabin KM, Shapiro CN, Schwarz KB (2003) Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 38:560–566

    Article  PubMed  Google Scholar 

  12. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S (2015) World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62:1190–1200

    Article  PubMed  CAS  Google Scholar 

  13. Dhingra S, Fiel MI (2014) Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med 138:1090–1097

    Article  PubMed  Google Scholar 

  14. Edmondson HA (1956) Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91:168–186

    CAS  PubMed  Google Scholar 

  15. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503

    Article  CAS  PubMed  Google Scholar 

  16. Eggel H (1901) Ueber das primäre Carcinom der Leber. Beitr Pathol Anat 30:506–604

    Google Scholar 

  17. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF (2013) Epidemiology of fibrolamellar hepatocellular carcinoma in the USA. Gut 62:1667–1668

    Article  PubMed  Google Scholar 

  18. El-Serag HB, Davila JA (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39:798–803

    Article  PubMed  Google Scholar 

  19. Evason KJ, Grenert JP, Ferrell LD, Kakar S (2013) Atypical hepatocellular adenoma-like neoplasms with beta-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol 44:750–758

    Article  CAS  PubMed  Google Scholar 

  20. Fernandez-Pineda I, Cabello-Laureano R (2014) Differential diagnosis and management of liver tumors in infants. World J Hepatol 6:486–495

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fernandez-Rodriguez CM, Gutierrez-Garcia ML (2014) Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther 5:175–182

    Article  PubMed  PubMed Central  Google Scholar 

  22. Forner A, Gilabert M, Bruix J, Raoul JL (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11:525–535

    Article  CAS  PubMed  Google Scholar 

  23. Frullanti E, La Vecchia C, Boffetta P, Zocchetti C (2012) Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis. Dig Liver 44:775–779

    Article  CAS  Google Scholar 

  24. Gadzijev EM, Pleskovic A, Stanisavljevic D, Ferlan-Marolt V, Trotovsek B (1998) Hepatobiliary cystadenoma can protrude and grow into the bile ducts. Hepatogastroenterology 45:1446–1451

    CAS  PubMed  Google Scholar 

  25. Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G (2014) Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment. Gut 63:1668–1676

    Article  CAS  PubMed  Google Scholar 

  26. Goldin RD, Rose DS (1990) Focal nodular hyperplasia of the liver associated with intracranial vascular malformations. Gut 31:554–555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gravante G, De Liguori Carino N, Overton J, Manzia TM, Orlando G (2008) Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg 25:364–368

    Article  PubMed  Google Scholar 

  28. Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 10:553–562

    Article  CAS  PubMed  Google Scholar 

  29. Haratake J, Horie A (1991) An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 68:93–97

    Article  CAS  PubMed  Google Scholar 

  30. Heeringa B, Sardi A (2001) Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection. Am Surg 67:927–929

    CAS  PubMed  Google Scholar 

  31. Huggins GR, Zucker PK (1987) Oral contraceptives and neoplasia: 1987 update. Fertil Steril 47:733–761

    Article  CAS  PubMed  Google Scholar 

  32. Hytiroglou P, Theise ND (1998) Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol 15:285–299

    CAS  PubMed  Google Scholar 

  33. Ikeda H, Harada K, Sato Y, Sasaki M, Yoneda N, Kitamura S, Sudo Y, Ooi A, Nakanuma Y (2013) Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. Am J Clin Pathol 140:329–340

    Article  PubMed  Google Scholar 

  34. Ishak KG (1979) Hepatic neoplasms associated with contraceptive and anabolic steroids. Recent Results Cancer Res 66:73–128

    CAS  PubMed  Google Scholar 

  35. Ito Y, Uesaka Y, Takeshita S, Fujino H, Uta Y, Yasuda H, Oshima M, Kawabe T, Tagawa K, Unuma T et al (1990) A case report of primary fibrosarcoma of the liver. Gastroenterol Jpn 25:753–757

    Article  CAS  PubMed  Google Scholar 

  36. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94:2040–2046

    Article  PubMed  Google Scholar 

  37. Ribeiro MAF Jr., Papaiordanou F, Goncalves JM, Chaib E (2010) Spontaneous rupture of hepatic hemangiomas: a review of the literature. World J Hepatol 2:428–433

    Article  PubMed  Google Scholar 

  38. Katsuda S, Kawahara E, Matsui Y, Ohyama S, Nakanishi I (1988) Malignant fibrous histiocytoma of the liver: a case report and review of the literature. Am J Gastroenterol 83:1278–1282

    CAS  PubMed  Google Scholar 

  39. Katsuramaki T, Nagayama M, Kimura Y, Meguro M, Furuhata T, Mukaiya M, Hirata K, Koito K, Hareyama M, Ikeda T, Satoh M (2003) Hepatocellular adenoma presenting as a giant multicystic tumor of the liver. J Gastroenterol 38:516–518

    Article  PubMed  Google Scholar 

  40. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006–2012

    Article  PubMed  Google Scholar 

  41. Kayler LK, Merion RM, Arenas JD, Magee JC, Campbell DA, Rudich SM, Punch JD (2002) Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation 74:128–130

    Article  PubMed  Google Scholar 

  42. Kim K, Choi J, Park Y, Lee W, Kim B (1998) Biliary cystadenoma of the liver. J Hepatobiliary Pancreat Surg 5:348–352

    Article  CAS  PubMed  Google Scholar 

  43. Kim SH, Park YN, Lim JH, Choi GH, Choi JS, Kim KS (2014) Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Eur J Surg Oncol 40:976–981

    Article  CAS  PubMed  Google Scholar 

  44. Kim YI, Yu ES, Lee KW, Park EU, Song HG (1987) Dedifferentiated liposarcoma of the liver. Cancer 60:2785–2790

    Article  CAS  PubMed  Google Scholar 

  45. Kirstein MM, Vogel A (2014) The pathogenesis of hepatocellular carcinoma. Dig Dis 32:545–553

    Article  PubMed  Google Scholar 

  46. Klatskin G (1977) Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 73:386–394

    Article  CAS  PubMed  Google Scholar 

  47. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW (2003) Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 10:1171–1175

    Article  PubMed  Google Scholar 

  48. Lederman SM, Martin EC, Laffey KT, Lefkowitch JH (1987) Hepatic neurofibromatosis, malignant schwannoma, and angiosarcoma in von Recklinghausen’s disease. Gastroenterology 92:234–239

    Article  CAS  PubMed  Google Scholar 

  49. Lee SS, Kim MH, Lee SK, Jang SJ, Song MH, Kim KP, Kim HJ, Seo DW, Song DE, Yu E, Lee SG, Min YI (2004) Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 100:783–793

    Article  PubMed  Google Scholar 

  50. Lindgren A, Olsson R (1993) Liver damage from low-dose oral contraceptives. J Intern Med 234:287–292

    Article  CAS  PubMed  Google Scholar 

  51. Lipshutz GS, Brennan TV, Warren RS (2002) Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 195:713–718

    Article  PubMed  Google Scholar 

  52. Liu M, Jiang L, Guan XY (2014) The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell 5:673–691

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, Chung SW, Scudamore CH, Ho SG (2003) Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 180:1359–1364

    Article  PubMed  Google Scholar 

  54. Marquardt JU, Thorgeirsson SS (2014) Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care. Cancer Cell 25:409–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Mayo SC, Mavros MN, Nathan H, Cosgrove D, Herman JM, Kamel I, Anders RA, Pawlik TM (2014) Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective. J Am Coll Surg 218:196–205

    Article  PubMed  Google Scholar 

  56. Meister P (1996) Malignant fibrous histiocytoma: histomorphological pattern or tumor type. Pathol Res Pract 192:877–881

    Article  CAS  PubMed  Google Scholar 

  57. Mettlin C, Natarajan N (1981) Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surgical Oncol 18:73–85

    Article  CAS  Google Scholar 

  58. Mistry AM, Gorden DL, Busler JF, Coogan AC, Kelly BS (2012) Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. J Gastrointest Cancer 43:521–525

    Article  PubMed  Google Scholar 

  59. Molina E, Hernandez A (2003) Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 48:677–682

    Article  PubMed  Google Scholar 

  60. Nakahama M, Takanashi R, Yamazaki I, Machinami R (1989) Primary fibrosarcoma of the liver. Immunohistochemical and electron microscopic studies. Acta Pathol Jpn 39:814–820

    CAS  PubMed  Google Scholar 

  61. Nakanuma Y, Tsutsui A, Ren XS, Harada K, Sato Y, Sasaki M (2014) What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma? Int J Hepatol 2014:805973

    Article  PubMed  PubMed Central  Google Scholar 

  62. Nault JC, Bioulac-Sage P, Zucman-Rossi J (2013) Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology 144:888–902

    Article  CAS  PubMed  Google Scholar 

  63. Njei B, Konjeti VR, Ditah I (2014) Prognosis of patients with fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis. Gastrointest Cancer Res 7:49–54

    PubMed  PubMed Central  Google Scholar 

  64. O’Connor K, Walsh JC, Schaeffer DF (2014) Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity. Ann Hepatol 13:317–322

    Article  PubMed  Google Scholar 

  65. O’Leary MR, Hill RB, Levine RA (1982) Peritoneoscopic diagnosis of primary leiomyosarcoma of liver. Hum Pathol 13:76–78

    Article  PubMed  Google Scholar 

  66. O’Sullivan MJ, Swanson PE, Knoll J, Taboada EM, Dehner LP (2001) Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 4:482–489

    Article  PubMed  Google Scholar 

  67. Parham DM, Reynolds AB, Webber BL (1995) Use of monoclonal antibody 1H1, anticortactin, to distinguish normal and neoplastic smooth muscle cells: comparison with anti-alpha-smooth muscle actin and antimuscle-specific actin. Hum Pathol 26:776–783

    Article  CAS  PubMed  Google Scholar 

  68. Pilati C, Letouze E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G, Mallet M, Taouji S, Balabaud C, Terris B, Canal F, Paradis V, Scoazec JY, de Muret A, Guettier C, Bioulac-Sage P, Chevet E, Calvo F, Zucman-Rossi J (2014) Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell 25:428–441

    Article  CAS  PubMed  Google Scholar 

  69. Raft MB, Jørgensen EN, Vainer B (2015) Gene mutations in hepatocellular adenomas. Histopathology 66:910–921

    Article  PubMed  Google Scholar 

  70. Sasaki M, Sato H, Kakuda Y, Sato Y, Choi JH, Nakanuma Y (2014) Clinicopathological significance of “subtypes with stem-cell feature” in combined hepatocellular-cholangiocarcinoma. Liver Int 35:1024–1035

    Article  PubMed  Google Scholar 

  71. Schwartz G, Colanta A, Gaetz H, Olichney J, Attiyeh F (2008) Primary carcinoid tumors of the liver. World J Surg Oncol 6:91

    Article  PubMed  PubMed Central  Google Scholar 

  72. Seki S, Sakaguchi H, Kitada T, Tamori A, Takeda T, Kawada N, Habu D, Nakatani K, Nishiguchi S, Shiomi S (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6:3469–3473

    CAS  PubMed  Google Scholar 

  73. Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31:49–60

    Article  PubMed  Google Scholar 

  74. Shafizadeh N, Genrich G, Ferrell L, Kakar S (2014) Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Hum Pathol 45:976–983

    Article  PubMed  Google Scholar 

  75. Soga J (2002) Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases. J Exp Clin Cancer Res 21:457–468

    CAS  PubMed  Google Scholar 

  76. Soini Y, Welsh JA, Ishak KG, Bennett WP (1995) p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis 16:2879–2881

    Article  CAS  PubMed  Google Scholar 

  77. Stocker JT (2001) Hepatic tumors in children. Clin Liver Dis 5:259–281

    Article  CAS  PubMed  Google Scholar 

  78. Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB 12:509–522

    Article  PubMed  PubMed Central  Google Scholar 

  79. Tannapfel A, Anhalt K, Hausermann P, Sommerer F, Benicke M, Uhlmann D, Witzigmann H, Hauss J, Wittekind C (2003) Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201:238–249

    Article  CAS  PubMed  Google Scholar 

  80. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, Engeland K, Wittekind C (1999) Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 91:1154–1158

    Article  CAS  PubMed  Google Scholar 

  81. Tannapfel A, Wittekind C (2001) Preneoplasia of the liver. Definition – differential diagnosis – clinical consequences. Pathologe 22:399–406

    Article  CAS  PubMed  Google Scholar 

  82. Tannapfel A, Wittekind C (2002) Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virch Arch 440:345–352

    Article  CAS  Google Scholar 

  83. Tarocchi M, Polvani S, Marroncini G, Galli A (2014) Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 20:11630–11640

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Theurillat JP, Vavricka SR, Went P, Weishaupt D, Perren A, Leonard-Meier C, Bachli EB (2003) Morphologic changes and altered gene expression in an epithelioid hemangioendothelioma during a ten-year course of disease. Pathol Res Pract 199:165–170

    Article  PubMed  Google Scholar 

  85. Tischoff I, Tannapfel A (2007) Hepatocellular carcinoma and cholangiocarcinoma – different prognosis, pathogenesis and therapy. Zentralbl Chir 132:300–305

    Article  CAS  PubMed  Google Scholar 

  86. Valla D, Benhamou JP (1988) Liver diseases related to oral contraceptives. Dig Dis 6:76–86

    Article  CAS  PubMed  Google Scholar 

  87. van Aalten SM, de Man RA, IJzermans JN, Terkivatan T (2012) Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 99:911–916

    Article  PubMed  Google Scholar 

  88. von Hochstetter AR, Hattenschwiler J, Vogt M (1987) Primary osteosarcoma of the liver. Cancer 60:2312–2317

    Article  Google Scholar 

  89. Wada Y, Jimi A, Nakashima O, Kojiro M, Kurohiji T, Sai K (1998) Schwannoma of the liver: report of two surgical cases. Pathol Int 48:611–617

    Article  CAS  PubMed  Google Scholar 

  90. Walsh R, Harrington J, Beneck D, Ozkaynak MF (2004) Congenital infantile hepatic hemangioendothelioma type II treated with orthotopic liver transplantation. J Pediatr Hematol Oncol 26:121–123

    Article  PubMed  Google Scholar 

  91. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi T (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197–2205

    Article  CAS  PubMed  Google Scholar 

  92. Weihrauch M, Bader M, Lehnert G, Koch B, Wittekind C, Wrbitzky R, Tannapfel A (2002) Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. Environ Mol Mutagen 40:36–40

    Article  CAS  PubMed  Google Scholar 

  93. Weihrauch M, Markwarth A, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A (2002) Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Hum Pathol 33:884–892

    Article  CAS  PubMed  Google Scholar 

  94. Weihrauch TR (2002) Pharmacogenetics – implications for health management and health care economics. Med Klin (Munich) 97:420–428

    Article  Google Scholar 

  95. Wittekind C (2017) TNM-Klassifikation maligner Tumoren. Wiley-VCH, Weinheim

    Google Scholar 

  96. Wright NB, Skinner R, Lee RE, Craft AW (1993) Myxoid liposarcoma of the porta hepatis in childhood. Pediatr Radiol 23:620–621

    Article  CAS  PubMed  Google Scholar 

  97. Young SJ (1975) Primary malignant neurilemmona (schwannoma) of the liver in a case of neurofibromatosis. J Pathol 117:151–153

    Article  CAS  PubMed  Google Scholar 

  98. Zheng SL, Yip VS, Pedica F, Prachalias A, Quaglia A (2015) Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature. Diagn Pathol 10:204

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pathologie, Deutsches Mesotheliomregister, Ruhr-Universität Bochum, Bochum, Deutschland

    Prof. Dr. Andrea Tannapfel

Authors
  1. Prof. Dr. Andrea Tannapfel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Tannapfel .

Editor information

Editors and Affiliations

  1. Institut für Pathologie, Ruhr-Universität Bochem, Bochum, Nordrhein-Westfalen, Germany

    Andrea Tannapfel

  2. Konsultationszentrum für Pankreas- und Endokrine Tumore, Technische Universität München, München, Germany

    Günter Klöppel

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tannapfel, A. (2020). Tumoren der Leber. In: Tannapfel, A., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04557-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04557-8_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04556-1

  • Online ISBN: 978-3-642-04557-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation